DXCM - Why DexCom (DXCM) Stock Hit A New 52-Week Low Today | Benzinga

DexCom, Inc. (NASDAQ: DXCM) shares are trading lower by 1.58% to $77.73 Thursday afternoon. The stock is trading lower on downward momentum after the FDA announced it had established a Digital Health Advisory Committee.

The stock has also been under pressure in 2023 amid the popularity of weight loss drugs.

What Happened?

The FDA has established a Digital Health Advisory Committee focused on addressing the complexities of digital health technologies, such as AI, augmented reality, and wearables. This ...

DXCM) Stock Hit A New 52-Week Low Today>Full story available on Benzinga.com